In Wyeth and Elan Pharma v. Under Sec. of Commerce for Intellectual Property, a panel of the Court of Appeals for the Federal Circuit (“CAFC”) recently affirmed the decision of the District Court for the District of Columbia to grant summary judgment that plaintiffs Wyeth and Elan Pharma (“Wyeth”) were entitled to extended patent term adjustments under 35 U.S.C. § 154(b) due to the Patent Office’s delay in prosecuting their applications. Continue Reading